UiPath announces agentic AI solutions for healthcare revenue cycle management at ViVE 2026, targeting medical records review, claim denials and prior authorization. The company argues that ...
UiPath’s PATH edge in today’s automation race comes down to one thing: how effectively its platform converts AI innovation into repeatable enterprise efficiency. The company is moving beyond scripted ...
UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. PATH's revenue growth re-accelerated to 15.9% in Q3 FY26, with raised full-year ...
The automation industry has spent the past year racing to pursue AI agents. UiPath’s new Chief Marketing Officer Michael Atalla pushes back on what that rush implies – not because agents lack value, ...
This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author. The acquisition expands and strengthens the UiPath portfolio of agentic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results